Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.23
+0.35 (5.95%)
At close: Sep 4, 2026, 4:00 PM EDT
6.24
+0.01 (0.16%)
After-hours: Sep 4, 2026, 7:53 PM EDT
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,911,125
Market Cap
597.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| ProKidney | 231 |
| Capricor Therapeutics | 231 |
| ARS Pharmaceuticals | 200 |
| Cabaletta Bio | 158 |
| Artiva Biotherapeutics | 115 |
| Scribe Therapeutics | 89 |
| Prelude Therapeutics | 79 |
ZURA News
- 1 day ago - Zura Bio management to meet with Piper Sandler - TheFly
- 4 days ago - Zura Bio to Participate in the Cantor Global Healthcare Conference - Business Wire
- 14 days ago - Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - Zura Bio price target raised to $20 from $15 at Guggenheim - TheFly
- 19 days ago - Zura Bio price target raised to $22 from $15 at Wedbush - TheFly
- 25 days ago - Zura Bio Slides: Corporate presentation - Filings
- 25 days ago - Zura Bio reports Q2 EPS (21c), consensus (19c) - TheFly
- 25 days ago - Zura Bio sees cash runway through the end of 2028 - TheFly